- Amid $55B US manufacturing push, J&J turns to streamlining its pharma supply chainAfter committing $55 billion last year to bolster U.S. manufacturing capabilities, Johnson & Johnson is making changes to its pharmaceutical supply chain.BioSpace · 11d ago↗ source
- STAT+: Bipartisan lawmakers want to require U.S. to probe reliance on foreign-made drugs, ingredientsA trio of bipartisan lawmakers reintroduced a bill requiring the FTC and Treasury to investigate whether the U.S. relies too heavily on foreign countries as part of its pharmaceutical supply…STAT · 11d ago↗ source
- STAT+: Elevance plots a Medicaid retreat as costs remain highElevance Health, the country’s second-biggest health insurer, said it plans to further shrink its Medicaid portfolio in the coming year, just as states roll out work requirements.